These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35312149)

  • 1. Microbotox: A prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea.
    Calvisi L; Diaspro A; Sito G
    J Cosmet Dermatol; 2022 Sep; 21(9):3747-3753. PubMed ID: 35312149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosacea in acne vulgaris patients: Subtype distribution and triggers assessment-A cross-sectional study.
    Chen H; Lai W; Zheng Y
    J Cosmet Dermatol; 2021 Jun; 20(6):1889-1896. PubMed ID: 33025720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acne rosacea: effectiveness of 532 nm laser on the cosmetic appearance of the skin.
    Maxwell EL; Ellis DA; Manis H
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):292-6. PubMed ID: 20470675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
    Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
    Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
    Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
    J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
    He G; Yang Q; Wu J; Huang Y; Zheng H; Cheng H
    J Cosmet Dermatol; 2024 Jan; 23(1):44-61. PubMed ID: 37605478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulin Toxin Use in Rosacea and Facial Flushing Treatment.
    Scala J; Vojvodic A; Vojvodic P; Vlaskovic-Jovicevic T; Peric-Hajzler Z; Matovic D; Dimitrijevic S; Vojvodic J; Sijan G; Stepic N; Wollina U; Tirant M; Thuong NV; Fioranelli M; Lotti T
    Open Access Maced J Med Sci; 2019 Sep; 7(18):2985-2987. PubMed ID: 31850105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recently approved systemic therapies for acne vulgaris and rosacea.
    Del Rosso JQ
    Cutis; 2007 Aug; 80(2):113-20. PubMed ID: 17944168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Uses of AbobotulinumtoxinA in Aesthetics.
    Schlessinger J; Gilbert E; Cohen JL; Kaufman J
    Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial.
    Niren NM; Torok HM
    Cutis; 2006 Jan; 77(1 Suppl):17-28. PubMed ID: 16871775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Topical Timolol 0.5% in the Treatment of Acne and Rosacea: A Multicentric Study.
    Al Mokadem SM; Ibrahim AM; El Sayed AM
    J Clin Aesthet Dermatol; 2020 Mar; 13(3):22-27. PubMed ID: 32308793
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
    Del Rosso JQ
    Cutis; 2006 Feb; 77(2 Suppl):22-4. PubMed ID: 16566285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical modalities for treating acne and rosacea.
    Jalian HR; Levin Y; Wanner M
    Semin Cutan Med Surg; 2016 Jun; 35(2):96-102. PubMed ID: 27416315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis.
    Aktaş Karabay E; Aksu Çerman A
    An Bras Dermatol; 2020; 95(2):187-193. PubMed ID: 32113677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acne vulgaris and acne rosacea as part of immune reconstitution disease in HIV-1 infected patients starting antiretroviral therapy.
    Scott C; Staughton RC; Bunker CJ; Asboe D
    Int J STD AIDS; 2008 Jul; 19(7):493-5. PubMed ID: 18574128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.
    Cho M; Woo YR; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2023 Dec; 103():adv18392. PubMed ID: 38078688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral 13-cis-retinoic acid therapy in adenoma sebaceum symmetricum and the most severe forms of acne and rosacea].
    Vogt E; Friederich HC
    Z Hautkr; 1983 May; 58(9):646-67. PubMed ID: 6223455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Acne and Rosacea Therapy.
    Stein Gold LF; Alexis AF; Harper JC; Tan JKL
    Semin Cutan Med Surg; 2018 Jun; 37(3S):S63-S66. PubMed ID: 30192344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.